Identifying human pre-mRNA cleavage and polyadenylation factors by genome-wide CRISPR screens using a dual

Zuyao Ni1, Nujhat Ahmed1,2, Syed Nabeel-Shah1,2

  • 1Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, ON M5S 3E1, Canada.

PubMed

Insights

Researchers developed a new CRISPR/Cas9 screening method to identify factors involved in messenger RNA 3' end processing (cleavage and polyadenylation). This system successfully identified known factors and new potential regulators like CCNK/CDK12.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Messenger RNA (mRNA) precursors undergo 3' end processing, a crucial step for gene expression, involving cleavage and polyadenylation (CPA).
  • Identifying human CPA factors has relied on biochemical and proteomic methods, lacking efficient genome-wide genetic screening approaches.
  • Understanding CPA factors is vital for regulating gene expression and cellular function.

Purpose of the Study:

  • To develop and validate a novel genome-wide screening method for identifying human cleavage and polyadenylation (CPA) factors.
  • To apply this system to discover new CPA factors and elucidate their roles in mRNA processing.
  • To provide a platform for studying CPA requirements in diverse cellular contexts.

Main Methods:

  • Development of a dual fluorescence readthrough reporter system to measure 3' end processing efficiency in living cells.
  • Integration of the reporter system with a human genome-wide CRISPR/Cas9 library for large-scale genetic screening.
  • Analysis of screening results to identify genes modulating CPA efficiency.

Main Results:

  • The screening successfully identified known core and auxiliary CPA factors, validating the system's reliability.
  • New potential CPA factors, including CCNK/CDK12 and RPRD1B, were identified.
  • RPRD1B was characterized as an RNA-binding factor regulating RNA polymerase II release during 3' end processing.

Conclusions:

  • The dual fluorescence reporter and CRISPR/Cas9 screening system is a powerful and reliable tool for identifying human CPA factors.
  • This approach expands the known repertoire of CPA factors and provides insights into novel regulatory mechanisms.
  • The developed platform facilitates future investigations into the functional roles of CPA factors in various biological settings.